01Dec
Covid–19 coronavirus: global merger review
Merger review processes are being impacted worldwide as merger control authorities adapt to take account of the consequences of Covid-19 coronavirus. While critical transactions are likely to be reviewed, as far as possible, in accordance with normal practice, many cases may face changes in approach and practice (eg extensions of timelines in certain circumstances). See our overview for an indication of the different approaches being taken by authorities around the world. Please see full...
By:
Allen & Overy LLP
Related
In a white paper and technical explanations, Republican Senators Charles E. Grassley (Chairman of th...
Read More >
On January 31, 2020, the United States Citizen and Immigration Services (USCIS) announced the releas...
Read More >
As the 2019 legislative year is about to come to a close, there are a number of critical labor and e...
Read More >
In today’s edition Sunday Book Review edition of Daily Compliance News: • Dare to Lead by Brené B...
Read More >
Amid FDI screening regime expansion, deal teams have opportunities to capitalise on newly available ...
Read More >
Since being enacted in the early 1990s, the Family and Medical Leave Act (FMLA) has provided meaning...
Read More >